Hair Repigmentation During Anti–PD-1 and Anti–PD-L1 Immunotherapy for Lung Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Hair Repigmentation During Immunotherapy Treatment With an Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Agent for Lung Cancer
JAMA Dermatol 2017 Jul 12;[EPub Ahead of Print], N Rivera, A Boada, MI Bielsa, MT Fernández-Figueras, E Carcereny, MT Moran, C FerrándizFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.